Lumida
/EFOR
⌘K
EFOR

EFOR

EFOR
$31.47USD+3.55%+1.08 today

MARKET CAP

1.3B

P/E (TTM)

FWD P/E

DAY RANGE

$30 – $32

52W RANGE

$17
$34

AI Summary

Stalk
Sell NowMedium

Despite a secular uptrend, weakening intermediate structure in a Stage 3 distribution phase and a confirmed double top with support failure signal that selling is favored. The recent breakdown below the 20EMA with follow-through and exhaustion from overbought conditions suggests exiting positions now. A supportive 50SMA lies well below, but until price reclaims the neckline and EMAs, bearish posture remains appropriate.

  • Secured $30M Defense Health Agency contract to modernize IT
  • Upgraded to Strong Buy by Zacks, driven by positive analyst revisions
  • Negative growth metrics limit market expansion potential
Full analysis →

The case for & against

Bull & Bear analysis

Bullish

Everforth, Inc. (NASDAQ: EFOR) is a prominent player in the defense and technology sector, providing specialized analytics, AI, cybersecurity, and cloud solutions. The company operates primarily within the Federal Government Segment, with a strong focus on helping government agencies modernize their IT healthcare systems. Recently, they secured a significant contract to support the Defense Health Agency, positioning themselves as a key contributor in the evolving landscape of military health IT solutions.

Bull says

  • Secured $30M Defense Health Agency contract to modernize IT
  • Upgraded to Strong Buy by Zacks, driven by positive analyst revisions
  • Earnings yield of 1.32 and book-to-price ratio of 3.52 indicate undervaluation
  • High QS score of 3.37 reflects robust balance sheet quality
  • Leverage is well managed, supporting capital efficiency
  • Potential for buybacks or dividends as financial metrics stabilize

Bear says

  • Negative growth metrics limit market expansion potential
  • Weak profitability metrics may hinder return generation
  • Downward momentum trend suggests continued price underperformance
  • High short interest reflects pronounced market skepticism
  • Rising competition and tech disruption risk contract wins
  • Operational uncertainties cloud outlook without performance improvements